Symbiotix Biotherapies

Read more
Nader Yaghoubi's photo - President & CEO of Symbiotix Biotherapies

President & CEO

Nader Yaghoubi

CEO Approval Rating

70/100

Founded

2009

Status

PrivateIndependent Company

Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Funding
$5M
Industry

Update Industry
Sector

Update Industry

Symbiotix Biotherapies News

Symbiotix Biotherapies Headquarters

1 International Pl Ste 1400 Suite 1400

Boston, Massachusetts02110

617-535-3196

Driving Directions »

Symbiotix Biotherapies Summary

ABOUT

Overview

Symbiotix develops molecular therapeutics based on the human microbiome. Symbiotix Biotherapies was founded in 2009. Symbiotix Biotherapies' headquarters is located in Boston, Massachusetts, USA 02110. Symbiotix Biotherapies' President & CEO, Nader Y...

CEO

Symbiotix Biotherapies's President & CEO, Nader Yaghoubi, currently has an approval rating of 70%. Symbiotix Biotherapies's primary competitors are

Competitors

There are no competitors identified for Symbiotix Biotherapies

Acquisitions

There have been no acquisitions found related to Symbiotix Biotherapies

Investments

Recent investment data cannot be found related to Symbiotix Biotherapies

Frequently Asked Questions about Symbiotix Biotherapies

  1. When was Symbiotix Biotherapies founded?

    Symbiotix Biotherapies was founded in 2009
  2. Who is Symbiotix Biotherapies's CEO?

    Symbiotix Biotherapies's CEO is Nader Yaghoubi
  3. How much revenue does Symbiotix Biotherapies generate?

    Symbiotix Biotherapies generates $ < 1M in revenue
  1. How much funding does Symbiotix Biotherapies have?

    Symbiotix Biotherapies has historically raised $5M in funding
  2. Where is Symbiotix Biotherapies's headquarters?

    Symbiotix Biotherapies's headquarters is in Boston Massachusetts, USA
  3. How many employees does Symbiotix Biotherapies have?

    Symbiotix Biotherapies has 0 employees

Trending Companies